| Dr Paul Kuperschmid, MD | |
|
6 Ohio Dr, Suite 201, Lake Success, NY 11042-1129 | |
| (516) 328-8700 | |
| (516) 328-8779 |
| Full Name | Dr Paul Kuperschmid |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 36 Years |
| Location | 6 Ohio Dr, Lake Success, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861463754 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 179940 (New York) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 179940 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Francis Hospital - The Heart Center | Roslyn, NY | Hospital |
| New York University Langone Medical Center | New york, NY | Hospital |
| North Shore University Hospital | Manhasset, NY | Hospital |
| Northwell Hospital Glen Cove | Glen cove, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
News Archive
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
RT Oncology Services Corporation ("RainTree"), the nation's leading community oncology alliance, and Express Scripts (NASDAQ: ESRX), the nation's leading pharmacy benefit manager, today announced that they have entered into an exclusive, three-year pharmaceutical drug distribution agreement.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today detailed recent developments in its product development portfolio and announced second quarter 2010 financial results.
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided "100% protection against a lethal dose of the Ebola virus" in a recent animal study published in The Journal of Infectious Diseases.
› Verified 8 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
RT Oncology Services Corporation ("RainTree"), the nation's leading community oncology alliance, and Express Scripts (NASDAQ: ESRX), the nation's leading pharmacy benefit manager, today announced that they have entered into an exclusive, three-year pharmaceutical drug distribution agreement.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today detailed recent developments in its product development portfolio and announced second quarter 2010 financial results.
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided "100% protection against a lethal dose of the Ebola virus" in a recent animal study published in The Journal of Infectious Diseases.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul Kuperschmid, MD 6 Ohio Dr, Suite 201, Lake Success, NY 11042-1129 Ph: (516) 328-8700 | Dr Paul Kuperschmid, MD 6 Ohio Dr, Suite 201, Lake Success, NY 11042-1129 Ph: (516) 328-8700 |
News Archive
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
RT Oncology Services Corporation ("RainTree"), the nation's leading community oncology alliance, and Express Scripts (NASDAQ: ESRX), the nation's leading pharmacy benefit manager, today announced that they have entered into an exclusive, three-year pharmaceutical drug distribution agreement.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today detailed recent developments in its product development portfolio and announced second quarter 2010 financial results.
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided "100% protection against a lethal dose of the Ebola virus" in a recent animal study published in The Journal of Infectious Diseases.
› Verified 8 days ago
Vincent Vinciguerra, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: The Monter Cancer Center, 450 Lakeville Road, Lake Success, NY 11042 Phone: 516-734-8954 | |
Lora Weiselberg, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: The Monter Cancer Center, 450 Lakeville Road, Lake Success, NY 11042 Phone: 516-734-8963 | |
Steve W Rucker, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4 Ohio Drive, Suite 200, Lake Success, NY 11042 Phone: 516-775-4545 Fax: 516-775-4646 | |
Richard Stark, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1999 Marcus Ave, Ste 120, Lake Success, NY 11042 Phone: 516-466-6611 Fax: 516-466-9582 | |
Ummekalsoom Rahman Malik, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 410 Lakeville Rd, Ste 311, Lake Success, NY 11042 Phone: 516-358-2400 Fax: 516-358-5454 | |
Clifford Cooper, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2 Pro Health Plz, Lake Success, NY 11042 Phone: 516-622-6020 | |
Francisco Antonio Garcia-moreno, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 410 Lakeville Rd, Ste 311, Lake Success, NY 11042 Phone: 516-358-2400 Fax: 516-358-5454 |